COVID–19 breakthrough infection after four doses of the vaccines: A case report

COVID–19 breakthrough infection after four doses of the vaccines: A case report

The COVID-19 vaccines provide a high degree of protection against severe disease, hospitalisation, and death. However, no vaccine claimed 100% effectiveness and it is expected that a small proportion of vaccinated individuals may develop a breakthrough infection due to individual differences, virus...

Full description

Bibliographic Details
Main Authors:	Hongrang Zhou, Guifu Li, Xiaoming Wang, Zhe Zhou, Wen Kong, Jingfei Hu, Kaiyou Ye, Wenjiang Zhong, Xiaoling Wang, Ning Xiao
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	One Health Bulletin
Subjects:	breakthrough infection; covid-19; vaccination
Online Access:	http://www.johb.info/article.asp?issn=2773-0344;year=2023;volume=3;issue=1;spage=7;epage=7;aulast=Zhou

Similar Items

Serological follow-up of anti-SARS-CoV-2 antibodies in blood donors after COVID-19 vaccine booster dose and breakthrough infections in Fuzhou
by: Shuhua JI, et al.
Published: (2023-12-01)

Factors influencing COVID-19 vaccine breakthrough infections: an analysis of healthcare workers in Ardabil, Iran
by: Elham Rezaei, et al.
Published: (2024-11-01)

Breakthrough Infections: A Challenge towards Measles Elimination?
by: Clara Fappani, et al.
Published: (2022-08-01)

Epidemiological characteristics of breakthrough mumps infection cases from 2019 to 2023 in Chongqing, China
by: Yang Liu, et al.
Published: (2024-12-01)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
by: Tafadzwa Dzinamarira, et al.
Published: (2022-02-01)

COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
by: Abeer N. Alshukairi, et al.
Published: (2022-06-01)

Incidence of breakthrough infections after COVID-19 vaccination among the COVID-19 vaccine recipients at a Tertiary Care Hospital in Srinagar
by: Anjum Fazili, et al.
Published: (2023-01-01)

Early-Life Antibiotic Exposure Associated With Varicella Occurrence and Breakthrough Infections: Evidence From Nationwide Pre-Vaccination and Post-Vaccination Cohorts
by: Teng-Li Lin, et al.
Published: (2022-03-01)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
by: Christina W. Stevens, et al.
Published: (2023-12-01)

Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
by: Andrea Lombardi, et al.
Published: (2024-03-01)

A study about the number of Coronavirus breakthrough infections during post vaccination period
by: Sudhir Bhatia
Published: (2024-02-01)

COVID-19 breakthrough infection among vaccinated individuals: A cross-sectional study
by: Sushant S Chavan, et al.
Published: (2022-07-01)

Breakthrough Infections of COVID-19 among Vaccinated Healthcare Workers in a Tertiary Care Hospital in Northern Kerala, India
by: Smrithi Surendranath, et al.
Published: (2022-06-01)

Onset age of mumps containing vaccine breakthrough cases with different vaccination doses and intervals
by: Haibo WANG, et al.
Published: (2023-07-01)

Correlation between Baseline 25(OH) Vitamin D Levels and Both Humoral Immunity and Breakthrough Infection Post-COVID-19 Vaccination
by: Rami Abu Fanne, et al.
Published: (2022-12-01)

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
by: Lauren A. Chang, et al.
Published: (2023-08-01)

COVID-19 breakthrough infections in vaccinated individuals at BPKIHS, Nepal
by: Abhishek Karmacharya, et al.
Published: (2024-09-01)

The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections
by: Vanessa di Lego, et al.
Published: (2022-06-01)

SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
by: Xiaohui Jing, et al.
Published: (2023-09-01)

SARS-CoV-2 vaccine breakthrough infection and the evaluation of safety precaution practice before and after vaccination among healthcare workers in South West, Nigeria
by: Oluwatosin Idowu Oni, et al.
Published: (2024-05-01)

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
by: Masataro Toda, et al.
Published: (2023-07-01)

Effect of SARS-CoV-2 Breakthrough Infection on HIV Reservoirs and T-Cell Immune Recovery in 3-Dose Vaccinated People Living with HIV
by: Meng-Meng Qu, et al.
Published: (2023-12-01)

Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population
by: Adeel A. Butt, et al.
Published: (2021-10-01)

Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review
by: Kristen Feemster, et al.
Published: (2023-11-01)

Comparative analyses of symptoms, severity, and breakthrough infections in vaccinated and unvaccinated individuals during three waves of COVID-19 in India
by: Priya Bhardwaj, et al.
Published: (2024-12-01)

Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy
by: Yingyu He, et al.
Published: (2023-05-01)

A comparison of clinical outcomes between vaccinated and vaccine-naive patients of COVID-19, in four tertiary care hospitals of Kerala, South India
by: Sabarish Balachandran, et al.
Published: (2022-01-01)

Breakthrough cases of mpox: One-dose vaccination is associated with milder clinical manifestations
by: Robert Allard, et al.
Published: (2024-04-01)

Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
by: Adeel A. Butt, MBBS, MS, et al.
Published: (2021-09-01)

Postvaccination breakthrough SARS-CoV-2 infections among adults in Malaysia and attitudes towards future vaccination
by: Praneetha Kumar Nair, et al.
Published: (2023-01-01)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
by: Matthieu Buscot, et al.
Published: (2023-03-01)

Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy
by: Sol Jin, et al.
Published: (2025-02-01)

COVID-19 vaccine breakthrough infection among health care workers at MODHS hospitals in Saudi Arabia: A multicenter study
by: Yazeed ELZahrany, et al.
Published: (2024-06-01)

Correlation of Sars-Cov-2 IGG Antibody Levels with Viral Load Among Vaccine Breakthrough Infections: A Study From Rawalpindi
by: Adnan Shahzad, et al.
Published: (2024-08-01)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
by: Thomas Perkmann, et al.
Published: (2023-08-01)

Characteristics of SARS-CoV-2 vaccine breakthrough infections among Chinese travelers entering China via Chengdu city
by: Lu LONG, et al.
Published: (2022-08-01)

Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients
by: Marco Masetti, et al.
Published: (2023-03-01)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
by: Patricia Almendro-Vázquez, et al.
Published: (2022-08-01)

Effect of Vaccination Time Intervals on SARS-COV-2 Omicron Variant Strain Infection in Guangzhou: A Real-World Matched Case–Control Study
by: Yufen Li, et al.
Published: (2022-11-01)

Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey
by: Shijie Qin, et al.
Published: (2023-12-01)